What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care
Recruiting
- Conditions
- Breast Carcinoma
- Interventions
- Other: Questionnaire Administration
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1000
- Registration Number
- NCT04794816
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
Phase 2
Recruiting
- Conditions
- Lung CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
- Interventions
- Other: Quality-of-Life Assessment
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT04789681
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Phase 1
Completed
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaMetastatic Triple-Negative Breast CarcinomaStage IVA Lung Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Pathologic Stage IV Cutaneous Melanoma AJCC v8Stage IVB Lung Cancer AJCC v8Hematopoietic and Lymphoid Cell NeoplasmMetastatic Melanoma
- Interventions
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT04789668
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis
Not Applicable
Active, not recruiting
- Conditions
- Liver and Intrahepatic Bile Duct Carcinoma
- Interventions
- Other: Clinical EvaluationOther: Laboratory Biomarker AnalysisProcedure: Liver Ultrasonographic ElastographyOther: Survey Administration
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1000
- Registration Number
- NCT04785534
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
Phase 1
Active, not recruiting
- Conditions
- Stage III Liver CancerStage IIIA Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Advanced Malignant Solid NeoplasmMetastatic Liver CarcinomaStage IV Lung Cancer AJCC v8Stage IVB Liver CancerAdvanced Lung CarcinomaMalignant Adrenal Gland Neoplasm
- Interventions
- Biological: Anti-CTLA4 Monoclonal Antibody BMS-986218Radiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 13
- Registration Number
- NCT04785287
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
Not Applicable
Recruiting
- Conditions
- Lung Carcinoma
- Interventions
- Other: Best PracticeOther: Medical Device Usage and EvaluationOther: Health Promotion and EducationOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 240
- Registration Number
- NCT04783168
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation
Phase 1
Withdrawn
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmRecurrent Chronic Lymphocytic LeukemiaRefractory Small Lymphocytic LymphomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaRichter Syndrome
- Interventions
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT04781855
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
Recruiting
- Conditions
- Cutaneous Melanoma
- Interventions
- Other: Medical Chart ReviewOther: Questionnaire Administration
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 5000
- Registration Number
- NCT04778449
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Expressive Writing for the Management of Stress in Cancer Survivors
Not Applicable
Recruiting
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
- Interventions
- Behavioral: Behavioral InterventionOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 414
- Registration Number
- NCT04776941
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
Early Phase 1
Withdrawn
- Conditions
- Sickle Beta ThalassemiaBeta Thalassemia MajorSickle Beta 0 ThalassemiaSickle Beta Plus ThalassemiaSickle Cell-SS DiseaseSickle Cell Disease
- Interventions
- Procedure: Hematopoietic Cell TransplantationProcedure: Plasmapheresis
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT04776850
© Copyright 2025. All Rights Reserved by MedPath